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7 ABSTRACT: The synthetic utility and theoretical basis of a
8 photolabile hydroxylamine-linker are presented. The devel-
9 oped protocols enable the eﬃcient synthesis and chemo-
10 selective photolytic release of either hydroxamates or
11 carboxamides from solid support. The bidetachable mode of
12 the linker unit is uniquely dependent on the solvent.
13 Hydroxamic acids are obtained by performing photolysis in protic solvents, whereas photolysis in aprotic solvents enables the
14 selective release of carboxamides.
15Hydroxamic acids have been the source of much16 biochemical interest in recent years.1 Therefore, the use
17 of solid-phase2 combinatorial chemistry3 for high-throughput
18 generation of structurally diverse hydroxamic acids is highly
19 relevant. Although hydroxamic acids may be obtained by direct
20 cleavage of resin-bound esters with hydroxylamine derivatives,4
21 this strategy requires an excess of hydroxylamine and/or
22 addition of base which complicates postcleavage workup.
23 Several approaches involving resin-bound hydroxylamine link-
24 ers have been reported.5 However, these hydroxamate linkages
25 suﬀer from only being cleavable under acidic conditions, which
26 limits the range of chemical transformations applicable to the
27 solid-phase synthesis of structurally diverse hydroxamic acids.
28 Therefore, other cleavage principles are necessary in order to
29 provide complex molecules assembled through a diverse range
30 of chemical reactivity. A linker system that can be cleaved under
31 photolytic conditions may be considered truly orthogonal in
32 this context.6 Futhermore, photolytic cleavage oﬀers a mild
33 method of cleavage which is particularly attractive for the direct
34 release of screening compounds into biological screens without
35 contamination by cleavage reagents.
36 We now wish to report a complete study on a photolabile
37 linker based on the o-nitroveratryl group7 capable of releasing
38 hydroxamates upon UV irradiation. Uniquely, this linker unit
39 may function as a “bidetachable” system. By simply varying the
40 reaction solvent, the photolysis can be controlled to provide
41 either C−O or C−N bond cleavage, which allows for controlled
f1 42 release of the hydroxamate or carboxamide, respectively (Figure
f1 43 1). This strategy may introduce further diversity into target
44 molecules and compound libraries. Linker 4 was readily
s1 45 prepared in a few high-yielding steps (Scheme 1)8 before
46 being explored as a hydroxamate-releasing linker. A N-[(1H-
47 benzotriazol-1-yl)(dimethylamino)-methylene]-N-methyl-
48 methanaminium tetraﬂuoroborate N-oxide (TBTU)-mediated
49 coupling of 4 to a Rink linker attached to the commercially
50 available amino-functionalized support (PEGA800) aﬀorded the
51hydroxylamine-functionalized photolabile support. Using stand-
52ard TBTU-mediated peptide coupling reactions, derivative 5a
53was synthesized as a simple and easily monitorable model
54system. Photolytic cleavage was carried out on resin suspended
55in H2O/MeOH (4:1) by irradiating for 30 min at rt with 365
56nm light using an LED UV-lamp. Analysis of the released
57material via RP-UPLC, however, showed release of two
58products: the hydroxamate 7a and the carboxamide 8a resulting
59from C−O and N−O cleavage, respectively, in a 3:4 ratio.
60The nature of the solvent9 and the acidity of the solution10,11
61have been demonstrated to have pronounced eﬀect on the
62kinetics and equilibrium position of aci-nitro compounds
63 f2(Figure 2). We ﬁrst explored the solvent eﬀects in the
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Figure 1. 4,5-Dialkoxy-2-nitrobenzyl moiety in photolabile linkers for
solid-phase synthesis.
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64 photolysis of 6a on the level of ﬁnal product formation. The
65 photoreaction was studied by photolyzing aliquots of the resin
66 6a in various solvents and determining the product distribution
67 via HPLC analysis. Because the solvent also inﬂuences the
68 swelling and solvation properties of the support, the obtained
69 results are merely qualitative. While this technique did not
70 allow us to quantify the amount of products formed, it did
71 provide an expedient method to determine the relative
72 photoproduct formation. Selected product yield proﬁles are
t1 73 listed in Table 1 (for a comprehensive list consult the
74 Supporting Information (SI)). It is evident that the solvent
75 has a strong inﬂuence on the product ratio of the reaction and
76 some general conclusions may be drawn. Polar solvents favor
77 formation of the hydroxamic acid product 7a, while apolar
78 solvents mainly give the carboxamide product 8a. In particular,
79 the polar ﬂuorinated alcohol, hexaﬂuoroisopropanol (HFIP),
80 with a high hydrogen-bond-donating ability led to hydroxamic
81 acid product 7a with high selectivity. Apolar solvents favor
82 formation of the carboxamide product 8a over hydroxamate
83 product 7a. Notably, when using mesitylene, carboxamide
84 product 8a was formed exclusively.
85The eﬀect of Lewis acid catalysis on the photoreaction of 5a
86has also been investigated (SI). The qualitative studies showed
87that a wide range of Lewis acids favor the formation of the
88hydroxamate product. The most eﬃcacious Lewis acid was
89found to be BF3, giving high selectivity toward formation of the
90hydroxamate product 8a.
91It is well-known that o-nitroveratryl compounds upon
92irradiation undergo a Norrish Type II β-hydrogen abstraction
93to give the biradical intermediate 11,12 which after photo-
94isomerization forms the E,Z-12 and Z,Z-12 isomers (Figure 2).
95From there it can again undergo isomerization to the E-aci-
96nitro forms 14EE and 14ZE. Measurements of aci-nitro transients
97have conﬁrmed the presence of 13− as an intermediate between
9812 and 14,11 and direct isomerization of 12 to 14 by rotation
99about the CN bond has been excluded.13,14 Also, the
100conversion of 12 to 14 via direct proton shift between the two
101oxygen atoms of the aci-nitro group (without participation of a
102water molecule) seems unlikely.15,11 The activation barrier
103computed by our density functional theory calculations yielded
104a barrier of 123 kJ mol−1 for this direct proton shift in the
105species 12 derived from 9, where R1 = Ph, R2 = Me.
106Furthermore, inclusion of a single water molecule to mediate
107the shift of this proton was computed to lower the activation
108barrier by at least 81 kJ mol−1 (see SI for computational
109details). The presence of additional water molecules in bulk
110solution should lower the activation barrier for water-mediated
111proton exchange even further.15 Taking this solvation eﬀect
112into account, water-mediated proton exchange (or proton
113transfer mediated by other protic solvents) via the anion 13 can
114be assumed to be the most likely path between the nitronic acid
115isomers 12 and 14, with an activation barrier of only a few kJ
116mol−1. Based on this discussion, we assume that the equilibrium
117between the two possible protonation sites on the nitronic acid
Scheme 1. (A) Synthesis of Fmoc-Protected Hydroxylamine-
Functionalized Carboxylic Acid Linker (4); (B) Application
of Linker 4 in Solid-Phase Peptide Synthesis (SPPS) for the
Photolytic Release of Peptide Hydroxamic Acids and
Carboxamides
Figure 2. Proposed mechanism for the photolytic degradation of hydroxamate-functionalized o-nitroveratryl derivatives. For simplicity, only the E-
isomers with regard to the C−OR group are shown.
Table 1. Relative Product Yields for Photolysis of 5a at 360
nm in Various Solvents
entrya solvent product 7a:8ab
A mesitylene 0:100
B MeOH/H2O (1:4) 67:33
C H2O 60:40
D HFIP 98:2
E mesitylene/HFIP (1:1) 98:2
aPhotolytic cleavage was carried out for 0.5 h with an LED UV-lamp
(360 nm). bProduct distribution was determined by RP-HPLC.
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118 function is established on the ns time scale in polar protic
119 solutions.
120 It is generally assumed that the decay of the aci-nitro forms is
121 the rate-limiting step in the photoisomerization of o-nitrobenzyl
122 derivatives and that cyclization to form intermediate 15
123 proceeds only from the neutral aci-tautomer 14.11−13 Under
124 conditions where interconversion between the two aci-nitro
125 forms is eﬃcient, we expect the “normal” hydroxamic acid
126 product forming pathway (14 → 15 → 16) to be fast.
127 However, in aprotic solvent where ionization to 13− does not
128 occur, the Z-aci-nitro species 12 give rise to a N−O bond
129 fragmentation pathway, which generates the amide and
130 nitroketone products 19 and 20. The proposed mechanism is
131 depicted in Figure 2.
132 To further investigate the photolysis of hydroxamate-
133 functionalized o-nitroveratryl compounds, we synthesized 21
134 (SI) as a model compound and studied the photolysis in
f3 135 solution (Figure 3). Hereby we were able to identify the nature
136 of byproducts formed in the photolysis of a hydroxamate-
137 functionalized o-nitroveratryl compound. Furthermore, solution
138 phase photolysis experiments provide the opportunity to study
139 the photolysis without inﬂuences from swelling and solvation
140 properties of the solid support. Photolysis of 21 was carried out
141 in a broad range of solvents (see SI). The low solubility of 21
142 did not allow an investigation of irradiation experiments in
143 mesitylene and saturated hydrocarbon solvents. In polar
144 solvents and in acidic solutions (CH3CN, HFIP, 1% TFA in
145 MeOH) the hydroxamic acid product formation is the only
146 observed pathway, while the apolar solvent toluene gave a
147 mixture of hydroxamic acid 7a and carboxamide 8a in a ratio of
148 1:1. Two examples of our results with 21 are shown in Figure 3.
149 Each peak in the chromatograms is characterized and identiﬁed
150 by UPLC-MS. In agreement with our proposed mechanism, we
151 observed from these experiments that the major byproduct
152 formed in polar solvents was o-nitrosobenzaldehyde 22, with
153 only minor impurities of 23, while o-nitrosobenzaldehyde 22
154 and o-nitrobenzaldehyde 23 were formed in a ratio of ∼1:1 in
155 toluene. The absence of other peaks in the chromatograms
156 indicates that no other side reactions had occurred. Conﬁdent
157 with the photolysis strategy, we employed the hydroxylamine
158 linker 4 for the parallel synthesis of a library of putatively
t2 159 HDAC inhibitors16 (Table 2 and SI). A Rink linker was
160 positioned between the support and the photolinker unit to
161 optimize and verify attachment chemistry of linker 4 on the
162 solid support. After incubating the supports 5a−e with TFA/
163 CH2Cl2 (1:1) for 2 h, one major peak corresponding to
164 cleavage of the Rink linker was generally observed (6a−e),
165 indicating high eﬃciency of the attachment chemistry of 4 and
166 high stability of the photolabile unit toward TFA deprotection
167 conditions normally used in standard peptide synthesis
168 procedures. Photolytic cleavage was carried out on 30−100
169mg of resin suspended in appropriate solvent by irradiating for
1700.5−3 h at rt with 365 nm light using an LED UV-lamp. We
171showed the possibility of selectively cleaving these compounds
172to give the hydroxamate and the carboxamide products,
173respectively. Selected examples of cleavage of a variety of
174compounds are presented in Table 2 (for a more elaborate
175study on cleavage of the full compound library, see SI). From
176Table 2 it can be concluded that the developed solid-phase
177methodology is very robust and applicable to a range of both
178aromatic and aliphatic hydroxamates. The liberated products
179were recovered in high purity (90−95%) and satisfactory yields
180(35−63%).
181While the linker 4 has been shown to be stable toward both
182acidic and basic condition, we investigated the utility of the
183linker for the synthesis of acid- and base-labile substrates. Both
184hydroxamate functionalized amino acid derivatives containing
185Boc- (7h) and Fmoc- (7g) protected α-amino groups, Trt-
186protected amide (7g), and Pbf-protected guanidinium (7h) side
187chain groups were successfully released, demonstrating the
188extraordinary protecting group compatibility of this linker resin.
189To further demonstrate the synthetic potential of the linker
190for the generation of more complex structures, we investigated
191the use of linker 4 for the synthesis of a derivative of a known
192diketopiperazine (DKP) hydroxamic acid HDAC inhibitor.17
193Massive eﬀorts in solid-phase synthesis have strived for the
194development of synthesis methodology, which systematically
195generates natural product-like compounds of high spatial
196complexity. In this context a current limitation is the diﬃculties
197faced in the synthesis of acid and base sensitive scaﬀolds,
198including racemization-prone structures. To demonstrate the
199use of linker 4 for the generation of the hydroxamate-
200functionalized DKP derivative 25, a serine-terminated oligo-
201meric peptide sequence 24 was assembled on a hydroxylamine-
202functionalized photolabile support by standard SPPS protocols.
203Exposing the resin 24 to classical periodate oxidation
Figure 3. Study of product distribution for the photolytic degradation
of 21 in HFIP and toluene, respectively.
Table 2. Synthesis and Photolytic Release of Hydroxamates
7a−h and Carboxamides 8a−h
aPhotolytic cleavage was carried out for 2 h with an LED UV-lamp
(360 nm). bPurity was determined by RP-HPLC.
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204 conditions generated the corresponding aldehyde, and
205 subsequent TFA treatment mediated the N-acyliminium
206 cyclization. Rewardingly, photolytic release gave the hydrox-
s2 207 amate-functionalized DKP-derivative 25 in high purity (Scheme
s2 208 2).
209 In summary, we have developed a photolabile hydroxylamine
210 linker for the synthesis of hydroxamic acids on solid support.
211 The synthesis strategy shows excellent compatibility with a
212 range of structurally diverse compounds. The linker is
213 compatible with most commonly used protecting groups for
214 SPPS and remains intact throughout the multistep synthesis.
215 Products are ultimately released from the solid support in high
216 purity using light. In addition, this linker unit may also function
217 in a bidetachable mode, enabling the release of the
218 corresponding carboxamides when photolysis is performed in
219 an aprotic solvent. Based on results from density functional
220 theory calculations, the present paper provides evidence of the
221 mechanism allowing for the control and selection between
222 these two competing reaction pathways. Finally, we have
223 demonstrated the use of the linker for the generation of a
224 pharmacologically relevant hydroxamate-functionalized natural
225 product-like DKP derivative in high purity.
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